MedTrace Logo

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

NCT06821945 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-09-15

No results posted yet for this study

Summary

The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia

Conditions

Interventions

DRUG

BR5402A

Subjects take the investigational products once a day

DRUG

BR5402A-1

Subjects take the investigational products once a day

DRUG

BR5402B

Subjects take the investigational products once a day

DRUG

BR5402B-1

Subjects take the investigational products once a day

DRUG

BR5402C

Subjects take the investigational products once a day

DRUG

BR5402C-1

Subjects take the investigational products once a day

DRUG

BR5402D

Subjects take the investigational products once a day

DRUG

BR5402D-1

Subjects take the investigational products once a day

Sponsors & Collaborators

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-30
Primary Completion
2027-05-31
Completion
2027-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06821945 on ClinicalTrials.gov